2ο Συνέδριο Ογκολογίας της Διασποράς

Alifragris C.

MRCP, PhD, Consultant Medical Oncologist & Honorary Associate Professor University College London Hospital & St. Bartholomew’ s Hospital, UK

Anagnostou A.

MD, PhD, Assistant Professor, Medical Oncology Director, Thoracic Oncology Biorepository Upper Aerodigestive Oncology Program, Co-leader, Molecular Tumor Board, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, USA

Anastasiadis P.

PhD, Professor of Cancer Biology, Deputy Director: May o Clinic Cancer Center, Rochester, USA

Andreopoulou E.

MD, Professor of Clinical Medicine, Director of the Breast Canc er Center Clinical Research Program, Weill Cornell Medicine Breast Center , New York, USA

Athanasiadis I.

Medical Oncologist, Director of Oncologic Clinic MITERA Hospital, Assistant Professor of Oncology, Northwestern University, USA

Boukovinas I.

MD, PhD, PharmaD, Medical Oncologist, Head of Oncology Unit, Bioclinic Thessaloniki, Greece

Boutis A.

Medical Oncologist, Theagenio Cancer Hospital, Thessalonki, Greece

Carystinos G.

General Manager, Ipsen Greece, Cyprus and Israel

Christopoulos C.

Radiation Oncologist, Head of R adiation Oncology Department, Groupe Hospitalier de Territoire Grand Paris Nord-Est, Paris, France

Dimitrakopoulos F.I.

MD, PhD, Medical Oncologist, Division of Oncology & Molecular O ncology Laboratory, Department of Medicine, Univ ersity of Patras, Greece

Dimopoulos A.

MD, PhD, Director of Radiation Oncology, Department Metropolitan Hospital, Medical University of Vienna, Estro Faculty Member

Galani E.

MD, Professor of Oncology and Sandr a J. Schulze Professor of Nov el Therapeutics, Executive Dean of Development, Mayo Clinic, Rochester, Minnesota, USA - Chair, Neuro-Oncology Committee, Alliance for Clinical Trials in Oncology

Georgoulias Vasileios

Emeritus Professor of Medical Oncology, School of Medicine, Uni versity of Crete, Heraklion, Crete

Giannakis M.

MD, PhD, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute. Assistant Professor of Medicine, Harvar d Medical School, Boston, USA

Gkika E.

Assoc. Professor, Vice Chair of the department of Radiation Oncology, Universitätsklinikum Freiburg, Freiburg, Germany

Golfinopoulos V.

MD, PhD, Medical Oncologist, Director , European Organisation for Research and Treatment of Cancer (EORTC), EORTC Headquarters

Grivas P.

MD, PhD, Associate Professor, Department of Medicine, Division of Medical Oncology, Clinical Director, Genitourinary Cancers Program, University of Washington, Associate Professor, Clinical Research Division, F red Hutchinson Cancer Research Center , USA

Kaklamani V.

MD DSc, Professor of Medicine, Leader , Breast Oncology Program, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, USA

Kalofonou M.

PhD, Research Fellow Cancer T echnology Lead, Centre for Bio-Inspired Technology, Dept. of Electrical & Electronic Engineering, Institute of Biom edical Engineering, Imperial College London, London, UK

Karachaliou N.

MD, PhD, Medical Director, Global Clinical Development, Merck KGaA, Darmstadt, Germany

Karagiannis S.

Professor of Translational Cancer Immunology and Immunotherapy, St. John’s Institute of Dermatology, School of Basic & Medical Biosciences , King’s College London, Guy’s Hospital, London, UK

Karasarides M.

PhD, Vice President, Worldwide Medical Oncology, Early Assets and Biomarkers, BMS, USA

Klinakis A.

PhD, Director of Research - Professor lev el, Biomedical Research Foundation of the Academy of Athens, Greece

Koinis F.

Assistant Professor of Medical Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Greece

Koliou P.

BS, MSc, MD, PhD, Consultant Medical Oncologist, Breast Lead an d Melanoma, Royal Surrey NHS Foundation T rust, Guildford, UK

Konstantis A.

Consultant Medical Oncologist, Princess Alexandra Hospital and UCL NHS Trust, UK

Kosmatopoulos K.

Chief Executive Officer, Vaxon Biotech, Paris, France

Kosmidis P.

Head, Medical Oncologist, 2 nd Medical Oncology Department, Hy geia Hospital

Kotoula V.

MD, PhD, Associate Professor, Dept of Pathology, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Greece

Kotsakis Athanasios

MD, PhD, Associate Professor of Medical Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Director of the Dpt of Medical Oncology University General Hospital of Larissa

Kouloulias V.

Professor of Radiation Oncology, School of Medicine, University of Athens, Scientific Director of Radiotherapy Unit, ATTIKON University Hospital, Athens, Greece

Leventakos K.

MD, PhD, Assistant Professor, Chest oncology and clinical studies phase 1, Mayo Clinic, Rochester, U.S.A.

Lianidou E.

Professor of Analytical Chemistry - Clinical Chemistry, Analysis of Circulating Tumor Cells (ACTC) Lab, Dept of Chemistry, University of Athens, Athens, Greece

Linardopoulos S.

Associate Director, Translational Science, Oncology AstraZeneca - Professor of Cancer Therapeutics, The Insitute of Cancer Research, London, UK

Linos K.

MD, FCAP, FASDP, Associate Professor of Pathology, Geisel School of Medicine at Dartmouth, USA, Bone & Soft Tissue pathology and Dermatopathology Division, Director of Bone & Soft Tissue Pathology Division, Dartmouth Hitchcock Medical Center , USA

Liontos M.

PhD, Medical Oncologist, Consultant, Department of Clinical Therapeutics, Alexandra Hospital, Athens, Greece

Logothetis C.J.

MD, Professor, Department of Genitourinary Medical Oncology, UT MD Anderson Cancer Center, Houston, USA

Lygerou Z.

PhD, Professor, Head, Department of Gener al Biology, Director of Studies, MSc Life Sciences Informatics, School of Medicine, Univ ersity of Patras, Patras, Greece

Makatsoris T.

Medical Oncologist , Associate Professor, School of Medicine, University of Patras, Division of Medical Oncology, Univ ersity Hospital of Patras, Patra, Greece

Metaxas Y.

MD, Senior Consultant Medical Oncology, Cantonal Hospital Muen sterlingen, Switzerland

Mountzios I.

MD, MSc, PhD, Medical Oncologist, Director, 4th Oncology Department and Clinical Trials Unit, Henry Dunant Hospital Center, ONCOLIFE Institute founder, Athens, Greece

Papadatos-Pastos D.

MRCP (UK) PhD, Consultant in Medical Oncology, Lung Cancer and Acute Oncology, University College London Hospitals and The Princess Alexandra Hospital, London, UK

Papadimitraki E.

Consultant Medical Oncologist, Breast Unit and Early Phase Trials, University College London Hospital, UK

Patrinos G.

Professor of Pharmacogenomics and Pharmaceutical Biotechnology, Department of Pharmacy, University of Patras, Patras, Greece - Full Member and Greece ’s National representative, European Medicines Agency, CHMP-Pharmacogenomics Working Party, Amsterdam, the Netherlands

Pelekanou V.

MD, PhD, Digital Pathology Leader, Senior Director, Oncology Precision Medicine, Bay er

Pentheroudakis G.

MD PhD, Chief Medical Officer , ESMO, Lugano, Switzerland, Professor of Oncology, Medical School, Univ ersity of Ioannina

Rovithi M.

Medical Oncologist, Agios Nikolaos General Hospital, Crete, Greece

Saridaki Z.

MD, PhD, Medical Oncologist, Scientific Director of the Oncology Department Asklepios DIAGNOSIS, Asklepeion Crete Clinic, Heraklion, Crete, Greece

Skoulidis F.

MD, PhD, Assistant Professor, Department of Thoracic and Head and Neck Medical Oncology, The University of Texas, MD Anderson Cancer Center, U.S.A.

Sotiriou C.

MD, PhD, Head of the Breast Cancer T ranslational Research Laboratory, Université Libre de Bruxelles, Full Professor, Medical Oncology Department, Institut Jules Bor det, Brussels, Belgium

Thanopoulou E.

MD, MHA, PhD, Lead Clinical Director | GDC-0077, Product Development - Oncology, Roche Products Limited, UK

Themeli M.

MD PhD, Assistant Professor, Department of Hematology, Location Vumc, Cancer Center Amsterdam, Amsterdam, the Netherlands

Tsantoulis P.

MD, PhD, Medical Oncologist, Department of Oncology, Univ ersity Hospital of Geneva, Center for Translational Oncohematology, University of Geneva (HUG), Swiss Cancer Center Leman, Geneva, Switzerland

Tsimperidou A.

MD, PhD, Department of Inv estigational Cancer Therapeutics, Division of Cancer Medicine, MD Anderson Cancer Center, USA

Tsoukalas N.

MD, MSc, PhD, Medical Oncologist, MSc Bioinf ormatics, Deputy Director, Oncology Department, 401 General Military Hospital and Consultant, Henry Dunant Hospital Center, Athens, Greece

Tsoutsou P.

MD PhD, Radiation Oncologist, Head of the R adiation Oncology Department, Geneva University Hospital, Geneva, Switzerland

Vasmatzis G.

Co-director of the Biomarker Discov ery Laboratory, Mayo Clinic Center for Individualized Medicine, Full Consultant in the Department of M olecular Medicine, Member of the Mayo Clinic Cancer Center, Rochester, USA

Zaromytidou A.I.

PhD, Chief Editor, Nature Cancer, Nature Portfolio, New York, NY

Πώς μπορώ να κάνω εγγραφή στην εκδήλωση;

Αφού έχετε κάνει σύνδεση με τους κωδικούς σας (σε περίπτωση που δεν έχετε κωδικούς ακολουθήστε τη διαδικασία δημιουργίας λογαριασμού), πατήστε το κουμπί "Εγγραφείτε στην εκδήλωση".

Θα ήθελα περισσότερες πληροφορίες σχετικά με τον χρόνο παρακολούθησης

Η καταγραφή του χρόνου παρακολούθησης αναγράφεται στη δεξιά πλευρά της σελίδας της εκδήλωσης που παρακολουθείτε. Η μέτρηση του χρόνου παρακολούθησης ξεκινάει εφόσον έχετε κάνει Subscription και εφόσον η εκδήλωση έχει ξεκινήσει. Η προβολή αυτού του πεδίου, πληροφορεί τον χρήστη για τον χρόνο (minutes) που έχει παρακολουθήσει.

Γιατί εμφανίζεται ένα pop-up window κατά τη διάρκεια της τρέχουσας εκδήλωσης;

Η εμφάνιση του pop-up window εξυπηρετεί στη διαφάνεια και στην αξιοπιστία των δεδομένων, που τελικά συλλέγονται μετά το πέρας της εκδήλωσης. Η διάρκεια εμφάνισης ενός pop-up window κατά την παρακολούθηση μίας live εκδήλωσης, είναι δύο λεπτά ενώ η επανάληψη εμφάνισης είναι περίπου ανά εξήντα λεπτά. Σε αυτό το διάστημα ο συμμετέχοντας της εκδήλωσης οφείλει να "απαντήσει", επιλέγοντας μία από τις δύο συνθήκες που εμφανίζονται στο pop-up window. Σε διαφορετική περίπτωση, το σύστημα θα διακόψει την καταγραφή του χρόνου παρακολούθησης.

Πώς μπορώ να υποβάλω μια ερώτηση προς τους ομιλητές;

Αφού έχετε κάνει σύνδεση και εγγραφή στην εκδήλωση, μπορείτε να υποβάλετε τις ερωτήσεις σας προς τους ομιλητές στο πεδίο που εμφανίζεται ακριβώς δίπλα στο παράθυρο αναμετάδοσης

Πώς μπορώ να λάβω το πιστοποιητικό μου;

Για να λάβετε το πιστοποιητικό σας, απαραίτητη προϋπόθεση είναι να έχετε επιλέξει το πεδίο "Εγγραφείτε στην εκδήλωση" καθώς και να έχετε παρακολουθήσει το 60% των συνολικών ωρών του επιστημονικού προγράμματος (αφορά σε ιατρικές επιστημονικές εκδηλώσεις). Στην σελίδα της εκδήλωσης και συμπληρώνοντας τη φόρμα αξιολόγησης, μπορείτε να λάβετε το πιστοποιητικό σας μέσω του πεδίου "ΚΑΤΕΒΑΣΤΕ ΤΟ ΠΙΣΤΟΠΟΙΗΤΙΚΟ ΣΑΣ". Τα πιστοποιητικά δίνονται με τη λήξη της επιστημονικής εκδήλωσης.

Ώρες λειτουργίας Τεχνικής Υποστήριξης:
- καθημερινά 09:00-17:00
- τις ημέρες του event 09:00-21:00
Μπορείτε να επικοινωνήσετε μαζί μας
στο τηλέφωνο +30 210 72 40 039
ή μέσω email support@livetime.gr

************************************

Technical Support is available:
- everyday 09:00-17:00
- at the day of the event 09:00-21:00
For Technical Support please contact us:
Phone: +30 210 72 40 039
Email: support@livetime.gr

2ο Συνέδριο Ογκολογίας της Διασποράς

LiveTIME powered by Scep